CD20 monoclonal antibody therapy for B-cell lymphona

Authors	L.E. van der Kolk
Supervisors	A.E.G.Kr. von dem Borne
Cosupervisors	M.H.J. van Oers
Award date	15-03-2001
ISBN	9090145885 9789090145884
Number of pages	124
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	Research conducted at: Geneeskunde, Immunologie
Language	English
Downloads	Thesis Cover Titlepage Table of contents Chapter 1 Introduction and outline of the thesis Chapter 2 Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy Chapter 3 Complement activation plays a key role in the side effects of rituximab treatment Chapter 4 Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils Chapter 5 Rituximab treatment results in impaired secondary humoral immune responsiveness Chapter 6 Intracellular pathways of CD20-induced apoptosis Chapter 7 Summary and General Discussion Samenvatting voor niet ingewijden Dankwoord Cover
Permalink to this page

Back

UvA-DARE